Cargando…

Epidemiology of tuberculosis in the Pacific island countries and areas, 2000–2020

OBJECTIVE: Tuberculosis (TB) is one of the most important infectious diseases with an estimated 9.9 million people falling ill globally in 2020. We describe the epidemiology of TB in the Pacific island countries and areas (PICs) to inform potential priority actions to implement the Western Pacific R...

Descripción completa

Detalles Bibliográficos
Autores principales: Yanagawa, Manami, Morishita, Fukushi, Oh, Kyung Hyun, Rahevar, Kalpeshsinh, Islam, Tauhidul Abm, Yadav, Subhash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Health Organization 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008724/
https://www.ncbi.nlm.nih.gov/pubmed/36923784
http://dx.doi.org/10.5365/wpsar.2023.14.1.996
_version_ 1784905822207213568
author Yanagawa, Manami
Morishita, Fukushi
Oh, Kyung Hyun
Rahevar, Kalpeshsinh
Islam, Tauhidul Abm
Yadav, Subhash
author_facet Yanagawa, Manami
Morishita, Fukushi
Oh, Kyung Hyun
Rahevar, Kalpeshsinh
Islam, Tauhidul Abm
Yadav, Subhash
author_sort Yanagawa, Manami
collection PubMed
description OBJECTIVE: Tuberculosis (TB) is one of the most important infectious diseases with an estimated 9.9 million people falling ill globally in 2020. We describe the epidemiology of TB in the Pacific island countries and areas (PICs) to inform potential priority actions to implement the Western Pacific Regional Framework to End TB 2021–2030. METHODS: A descriptive analysis was conducted using annual TB surveillance data submitted by national TB programmes to the World Health Organization (WHO) and TB burden estimates (incidence rates and number of deaths) generated by WHO for the PICs, for the period 2000–2020. We also analysed TB case numbers, multidrug-resistant/rifampicin-resistant TB (MDR/RR-TB), recent risk factor indicators and treatment outcomes. RESULTS: The estimated TB incidence rate in the PICs increased between 2000 and 2020 from 62 to 69 per 100 000 population, with an 8% reduction observed since 2015. TB cases increased by 29% during 2000–2020, with 1746 cases in 2020 and a high proportion in children (19%). Bacteriological diagnosis was used for 58% of total TB cases, although some countries reported clinical diagnoses in over 60% of cases. From 2015 to 2019, 52 MDR/RR-TB cases were reported and there were 94 TB/HIV coinfected cases in 2015–2020. Treatment success was 74% in 2019 due to 18% of cases being unevaluated. In 2020, the estimated proportion of TB cases attributable to smoking, malnutrition, alcohol abuse and diabetes was 17%, 16%, 11% and 9%, respectively. DISCUSSION: There was an increasing trend in TB cases, estimated incidence and deaths between 2000 and 2020. Laboratory services were scaled up in some PICs and case-finding activities greatly contributed to the detection of cases. To end the incidence of TB, continued efforts on case finding, contact investigation and scaling up TB preventive treatment should be prioritized. At the same time, collaboration with other sectors for risk factor management and decentralized management need to be considered.
format Online
Article
Text
id pubmed-10008724
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher World Health Organization
record_format MEDLINE/PubMed
spelling pubmed-100087242023-03-14 Epidemiology of tuberculosis in the Pacific island countries and areas, 2000–2020 Yanagawa, Manami Morishita, Fukushi Oh, Kyung Hyun Rahevar, Kalpeshsinh Islam, Tauhidul Abm Yadav, Subhash Western Pac Surveill Response J Non Theme Issue OBJECTIVE: Tuberculosis (TB) is one of the most important infectious diseases with an estimated 9.9 million people falling ill globally in 2020. We describe the epidemiology of TB in the Pacific island countries and areas (PICs) to inform potential priority actions to implement the Western Pacific Regional Framework to End TB 2021–2030. METHODS: A descriptive analysis was conducted using annual TB surveillance data submitted by national TB programmes to the World Health Organization (WHO) and TB burden estimates (incidence rates and number of deaths) generated by WHO for the PICs, for the period 2000–2020. We also analysed TB case numbers, multidrug-resistant/rifampicin-resistant TB (MDR/RR-TB), recent risk factor indicators and treatment outcomes. RESULTS: The estimated TB incidence rate in the PICs increased between 2000 and 2020 from 62 to 69 per 100 000 population, with an 8% reduction observed since 2015. TB cases increased by 29% during 2000–2020, with 1746 cases in 2020 and a high proportion in children (19%). Bacteriological diagnosis was used for 58% of total TB cases, although some countries reported clinical diagnoses in over 60% of cases. From 2015 to 2019, 52 MDR/RR-TB cases were reported and there were 94 TB/HIV coinfected cases in 2015–2020. Treatment success was 74% in 2019 due to 18% of cases being unevaluated. In 2020, the estimated proportion of TB cases attributable to smoking, malnutrition, alcohol abuse and diabetes was 17%, 16%, 11% and 9%, respectively. DISCUSSION: There was an increasing trend in TB cases, estimated incidence and deaths between 2000 and 2020. Laboratory services were scaled up in some PICs and case-finding activities greatly contributed to the detection of cases. To end the incidence of TB, continued efforts on case finding, contact investigation and scaling up TB preventive treatment should be prioritized. At the same time, collaboration with other sectors for risk factor management and decentralized management need to be considered. World Health Organization 2023-02-22 /pmc/articles/PMC10008724/ /pubmed/36923784 http://dx.doi.org/10.5365/wpsar.2023.14.1.996 Text en (c) 2023 The authors; licensee World Health Organization. https://creativecommons.org/licenses/by/3.0/igo/This is an open access article distributed under the terms of the Creative Commons Attribution IGO License (http://creativecommons.org/licenses/by/3.0/igo/legalcode (https://creativecommons.org/licenses/by/3.0/igo/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any reproduction of this article there should not be any suggestion that WHO or this article endorse any specific organization or products. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL.
spellingShingle Non Theme Issue
Yanagawa, Manami
Morishita, Fukushi
Oh, Kyung Hyun
Rahevar, Kalpeshsinh
Islam, Tauhidul Abm
Yadav, Subhash
Epidemiology of tuberculosis in the Pacific island countries and areas, 2000–2020
title Epidemiology of tuberculosis in the Pacific island countries and areas, 2000–2020
title_full Epidemiology of tuberculosis in the Pacific island countries and areas, 2000–2020
title_fullStr Epidemiology of tuberculosis in the Pacific island countries and areas, 2000–2020
title_full_unstemmed Epidemiology of tuberculosis in the Pacific island countries and areas, 2000–2020
title_short Epidemiology of tuberculosis in the Pacific island countries and areas, 2000–2020
title_sort epidemiology of tuberculosis in the pacific island countries and areas, 2000–2020
topic Non Theme Issue
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008724/
https://www.ncbi.nlm.nih.gov/pubmed/36923784
http://dx.doi.org/10.5365/wpsar.2023.14.1.996
work_keys_str_mv AT yanagawamanami epidemiologyoftuberculosisinthepacificislandcountriesandareas20002020
AT morishitafukushi epidemiologyoftuberculosisinthepacificislandcountriesandareas20002020
AT ohkyunghyun epidemiologyoftuberculosisinthepacificislandcountriesandareas20002020
AT rahevarkalpeshsinh epidemiologyoftuberculosisinthepacificislandcountriesandareas20002020
AT islamtauhidulabm epidemiologyoftuberculosisinthepacificislandcountriesandareas20002020
AT yadavsubhash epidemiologyoftuberculosisinthepacificislandcountriesandareas20002020